Evaluating the impact of a switch to nilotinib on imatinib-related chronic low-grade adverse events in patients with CML-CP: the ENRICH study by Cortes, Jorge E., MD, Lipton, Jeffrey H., FRCPC, MD, PhD, Miller, Carole B., MD, Busque, Lambert, MD, Akard, Luke P., MD, Pinilla-Ibarz, Javier, MD, PhD, Keir, Christopher, MD, MS, Warsi, Ghulam, PhD, Lin, Felice P., PharmD, Mauro, Michael J., MD

Get full text